SlideShare a Scribd company logo
Miss. Aarti V. Shingan
M. Pharm in pharmaceutical Chemistry
 Known as :prostaglandin-endoperoxide
synthase(PTGS)
 Responsible for formation of prostanoides
1.prostaglandin,
 2.thamboxen,
 3.prostacylin.
 Involved in the inflammtory Responce.
 Contains two separate active sites for
prostaglandin synthase
 One side contains the cyclooxygenase active
 The Opposite active side active side contains
peroxidase active site which is Involved in
activating the heme group neccesory for
cyclooxygenase reaction
 It has two forms COX-1 and COX-2.
 Continiously stimulate by the body
 Constitutive (its concentration in the body
remain stable)
 creates prostaglandin uses for basic house
keeping throughout the body
 Prostaglandin stimulate normal body
function such as stomach mucous
production, regulation of gastric acid and
kidney water
 Induced ( normally not in present in cells)
 Built only in special cells (Ex: lung cells)
 Used for singnaling pain and inflamation
 Produces prostaglandins for inflammtory
responce
 Stimulated only as part of immune
responce
 Production is stimulated by inflammtory
cytokines and growth factors
Flurbiprofen Ibuprofen
Tolmetin
Indomethacin Ketoprofen
IUPAC Name :
1-(p-Chloro benzoyl) 5-
methoxy indole-3-acitic
acid
Properties :
Colour: pale yellow
appearance: crystalline powder
solubility: soluble in water sparingly soluble in alcohol
M.P : 155-162 0C
chemical formula: C19H21ClNNaO7
Assay: the sample in acetone and pass nitrogen for 15 min
and titrate with 0.1M NAOH using phenolphthalein as
indicator.
1. The centre of acidity is usually located one carbon atom
adjecent to a flat surface represented by an aromatic or hetero
aromatic ring .
2. The distance between these centre is critical because
increasing this distance to two or three carbon generally
decreasing activity.
3. Increasing acidity of of COOH group Increasing activity.
4. Substitution of methyl group on the carbon atom separating
the aromatic ring leads to the enhancement of anti-
inflammatory activity.
P –methoxy
phenyl hydrazine hydrazone
indomethacin
Mechanism of action :
indomethacin ,a non –steroidal anti-inflmmatory drug
(NSAIDs) ,it is a selective COX-1 inhibitor
the enzyme that participate in prostaglandin synthesis
from archidonic acid
Prostaglandin are hormone like molecule normally found in
the body , where they have a wide variety of effects, some
of which leads to pain ,fever, and inflammation.
By inhibiting the synthesis of prostaglandins , indomethacin
can reduce pain, fever, and inflammation.
Medical uses:
 indomethacin is an analgesic,antipyretic and anti-
inflammatory . Clinical indication for indomethacin
include :
 Joint diseases : rheumatoid arthritis ,oateoarthritis
,gouty arthritis ;Headaches etc
Adverse effect: peptic ulcer ,dypepsia,heartburn,mild
dirrhea ,edema9swelling due to fluid retention ) ,
hyperkalemia(highpotassiumlevel), hypernatremia(high
sodium level ) .
 IUPAC Name :
2-(4-isobutyl
phenyl) propionic
acid
Properties :
Colour: colourless ,
appearance: crystalline powder
solubility: insoluble in water, soluble in most organic
solvents like alcohols, acetone,and dichloromethane.
M.P : 75-780C
chemical formula: C13H18O2
Assay: Dissolve the sample in methanol and titrate
against 0.1M NaOH USING Phenolphthalin indicator as
indicator ,until colour is obtained .
Mechanism of action: it is a non –steroidal anti-inflmmatory
drug (NSAIDs) ,it is a selective COX-1 inhibitor
the enzyme that participate in prostaglandin synthesis
from archidonic acid
Prostaglandin are hormone like molecule normally found in
the body , where they have a wide variety of effects, some
of which leads to pain ,fever, and inflammation.
By inhibiting the synthesis of prostaglandins , ibuprofen
can reduce pain, fever, and inflammation
Medical uses:
 Ibuprofen is used primarily to treat fever (including post-
vaccination fever),
 mild to moderate pain (including pain relief after surgery),
painful menstruation, osteoarthritis, dental pain,
headaches, and pain from kidney stones.
 About 60% of people respond to any NSAID; those who do
not respond well to a particular one may respond to
another.
 It is used for inflammatory diseases such as juvenile
idiopathic arthritis and rheumatoid arthritis.
 It is also used for pericarditis and patent ductus arteriosus.
Adverse effects :
 include nausea, dyspepsia, diarrhea, constipation,
gastrointestinal ulceration/bleeding, headache, dizziness,
rash, salt and fluid retention, and high blood pressure.
 Infrequent adverse effects include esophageal ulceration,
heart failure, high blood levels of potassium, kidney
impairment, confusion, and bronchospasm.Ibuprofen
can exacerbate asthma
 IUPAC name :
2-(6-methoxy
2-naphthyl)
propionic acid
Properties :
Colour: white
appearance: crystalline powder
solubility insoluble in water, soluble in most organic
solvents like methanol,ethanol.
M.P : 155-162 0C
chemical formula: C19H21ClNNaO7
Assay: dissolve the sample in a mixture of water and
methanol(1:3)and titrate with 0.1M NAOH using
phenolphthalein as indicator.
Mechanism of action: it is a non –steroidal anti-
inflmmatory drug (NSAIDs) ,it is a selective COX-1
inhibitor
the enzyme that participate in prostaglandin synthesis
from archidonic acid
Prostaglandin are hormone like molecule normally found
in the body , where they have a wide variety of effects,
some of which leads to pain ,fever, and inflammation.
By inhibiting the synthesis of prostaglandins , naproxen
can reduce pain, fever, and inflammation.
Medical uses :
Inflammatory sources of pain that may respond to
naproxen's anti-inflammatory activity are conditions
 such as migraine,
 osteoarthritis,
 kidney stones,
 rheumatoid arthritis,
 psoriatic arthritis,
 gout,
 ankylosing spondylitis,
 menstrual cramps, tendinitis, and bursitis.
adverse effects:
include
 dizziness, drowsiness,
 headache,
 rash,
 bruising,
 gastrointestinal upset.
 Heavy use is associated with increased risk of end-
stage renal disease and kidney failure.
 IUPAC Name:2-
(1-methyl-5-(4-
methylbenzoyl)-
1H-pyrrole2-
yl)acetate
Properties :
Colour: light yellow,
appearance: crystalline powder
solubility soluble in water, slightly soluble
solvents like methanol,ethanol.
M.P : 155-157 0C
chemical formula: C15H15NO3
Mechanism of action:
 Although the mechanism of action of tolmetin is
unknown, research involving humans and animals has
shown that tolmetin does not achieve anti-inflammatory
response by stimulation of the adrenal or pituitary gland,
 but it has shown tolmetin restrains prostaglandin
synthetase in vitro and reduces plasma levels of
prostaglandin E, possibly causing the anti-inflammatory
response.
Medical uses: Is used alone or with other treatment to reduce
pain , swelling, and joint stiffness from rheumatoid arthritis and
osteoarthritis . It is used for juvenile rheumatoid arthrites
Adverse effect:
 Tolmetin can increase the risk of heart or circulatory conditions
such as heart attacks and strokes. It should not be taken shortly
before or after coronary artery bypass surgery.
 Tolmetin can also increase the risk of gastrointestinal conditions
such as perforation or bleeding, which is fatal. Antacids can be
taken with tolmetin to relieve stomachaches that often occur.
 Overdose can result in drowsiness, nausea, epigastric pain, and
vomiting
Adverse effect:
 Tolmetin can increase the risk of heart or circulatory
conditions such as heart attacks and strokes.
 It should not be taken shortly before or after coronary
artery bypass surgery.
 Tolmetin can also increase the risk of gastrointestinal
conditions such as perforation or bleeding, which is fatal.
Antacids can be taken with tolmetin to relieve
stomachaches that often occur.
 Overdose can result in drowsiness, nausea, epigastric pain,
and vomiting.
IUPAC Name:
4-[5-(4-methyl phenyl)3-
(trifluoro)1Hpyrazolyl)
Benzene sulphonamide
Drug name :CELEBREX
Properties :
Colour: pale yellow
appearance: crystalline powder
solubility: soluble in water sparingly soluble in
alcohol
M.P : 157-159 0C
chemical formula: C17H14FNO2S
 A para-sulfamoylphenyl at position 1 of the pyrazole was
found to have a higher potency for COX-2 selective inhibition.
 At the 3-position of the pyrazole, a trifluoromethyl or
difluoromethyl provides superior selectivity and
potencyCelecoxib is compound 22;
 the 4-sulfamoylphenyl on the 1-pyrazol substituent is
required for COX-2 inhibition and the 4-methyl on the 5-
pyrazol system has low steric hindrance to maximize potency,
 while the 3-trifluoromethyl group provides superior
selectivity and potency.
 To explain the selectivity of celecoxib, it is necessary to
analyze the free energy of binding difference between the
drug molecule and COX-1 compared to COX-2 enzymes
 Celecoxib is used for osteoarthritis, rheumatoid
arthritis, acute pain, musculoskeletal pain,
painful menstruation, ankylosing spondylitis, and to reduce
the number of colon and rectal polyps in people with familial
adenomatous polyposis.
 It may also be used in children with juvenile rheumatoid
arthritis who are older than two years of age and weigh more
than 10 kg (22 lb).
Mental illness
 Tentative evidence supports its use in treating a number of
psychiatric disonrders, including major depression, bipolar
disorder, and schizophrenia.
 Familial adenomatous polyposis
Adverce effect:
 Cardiovascular events: NSAIDs are associated with an increased
risk of serious (and potentially fatal) adverse cardiovascular
thrombotic events, including myocardial infarction and stroke
 Gastrointestinal events: NSAIDs may increase risk of serious
gastrointestinal (GI) ulceration, bleeding, and perforation (may
be fatal). These events may occur at any time during therapy
and without warning.
 Use cautionHematologic effects: Anemia may occur;
monitor hemoglobin or hematocrit in people on long-
term treatment. Celecoxib does not usually
affect prothrombin time, partial thromboplastin
time or platelet counts; it does not inhibit platelet
aggregation at approved doses.
 with a history of GI disease (bleeding or ulcers).
IUPAC Name:
4[4(methylsulfonyl)p
henyl]-3phenylfuran-
2 furonone
Properties :
Colour: light yellow
appearance: crystalline powder
solubility: . Soluble in 1- octanol ,soluble in water
sparingly soluble in alcohol , acetone
M.P : 155-162 0C
chemical formula: C17H14O4S
ROFICOXIB
Mechanism of action
Cyclooxygenase (COX) has two well-studied isoforms,
called COX-1 and COX-2. COX-1 mediates the
synthesis of prostaglandins responsible for protection
of the stomach lining, while COX-2 mediates the
synthesis of prostaglandins responsible for pain and
inflammation.
By creating "selective" NSAIDs that inhibit COX-2, but
not COX-1, the same pain relief as traditional NSAIDs
is offered, but with greatly reduced risk of fatal or
debilitating peptic ulcers. Rofecoxib is a selective
COX-2 inhibitor, or "coxib"
 Medical uses :Rofecoxib is a nonsteroidal
anti-inflammatory drug that was used in the
treatment of osteoarthritis, acute pain
conditions, and dysmenorrhoea.
 Adverce effect:Aside from the reduced
incidence of gastric ulceration, rofecoxib
exhibits a similar adverse effect profile to
other NSAIDs.
Thank you

More Related Content

What's hot

Strategies for Heterocycle ring synthesis
Strategies for Heterocycle ring synthesis Strategies for Heterocycle ring synthesis
Strategies for Heterocycle ring synthesis
SACHINKUMARVISHWAKAR4
 
Traube purine synthesis
Traube purine synthesisTraube purine synthesis
Traube purine synthesis
Karanvir Rajput
 
Protecting groups
Protecting groupsProtecting groups
Protecting groups
VIKAS MATHAD
 
Rational design of non- covalently and covalently binding.pptx
Rational design of non- covalently and covalently binding.pptxRational design of non- covalently and covalently binding.pptx
Rational design of non- covalently and covalently binding.pptx
RashuRaju
 
Active constituent of drugs used in diabetic therapy
Active constituent of drugs used in diabetic therapyActive constituent of drugs used in diabetic therapy
Active constituent of drugs used in diabetic therapy
Akshay Kank
 
AMC PPT 4.pptx
AMC PPT 4.pptxAMC PPT 4.pptx
AMC PPT 4.pptx
Aparna Appu
 
Ullmann reaction
Ullmann reaction   Ullmann reaction
Ullmann reaction
Aanchal Gupta
 
01.Rational Design of Enzyme inhibition.pptx
01.Rational Design of Enzyme inhibition.pptx01.Rational Design of Enzyme inhibition.pptx
01.Rational Design of Enzyme inhibition.pptx
PurushothamKN1
 
Wittig reagent
Wittig reagentWittig reagent
Wittig reagent
andhra university
 
Chemistry of Prostaglandins, leukotrienes and thromboxanes(Advance medicinal ...
Chemistry of Prostaglandins, leukotrienes and thromboxanes(Advance medicinal ...Chemistry of Prostaglandins, leukotrienes and thromboxanes(Advance medicinal ...
Chemistry of Prostaglandins, leukotrienes and thromboxanes(Advance medicinal ...
Rohit kaushiK.
 
Pinner pyrimidine synthesis
Pinner pyrimidine  synthesisPinner pyrimidine  synthesis
Pinner pyrimidine synthesis
JACOB THON BIOR
 
Natural chemistry Structure elucidation of Emetine
Natural chemistry Structure elucidation of EmetineNatural chemistry Structure elucidation of Emetine
Natural chemistry Structure elucidation of Emetine
Anam Ilyas
 
Protecting Groups in Organic Chemistry
Protecting Groups in Organic ChemistryProtecting Groups in Organic Chemistry
Protecting Groups in Organic Chemistry
Ajay Kumar
 
01. Combating Drug Resistance.pptx
01. Combating Drug Resistance.pptx01. Combating Drug Resistance.pptx
01. Combating Drug Resistance.pptx
PurushothamKN1
 
"Chemistry of Prostaglandins & Leukotrienes" , Tathagata Pradhan , Department...
"Chemistry of Prostaglandins & Leukotrienes" , Tathagata Pradhan , Department..."Chemistry of Prostaglandins & Leukotrienes" , Tathagata Pradhan , Department...
"Chemistry of Prostaglandins & Leukotrienes" , Tathagata Pradhan , Department...
Tathagata Pradhan, Indo Soviet Friendship College of Pharmacy, Moga, Punjab
 
TRAUBE PURINE SYNTHESIS.pptx
TRAUBE PURINE SYNTHESIS.pptxTRAUBE PURINE SYNTHESIS.pptx
TRAUBE PURINE SYNTHESIS.pptx
PratikKapse8
 
Chemistry of Natural Products, Morphine Alkaloids.pptx
Chemistry of Natural Products, Morphine Alkaloids.pptxChemistry of Natural Products, Morphine Alkaloids.pptx
Chemistry of Natural Products, Morphine Alkaloids.pptx
Jubair Sikdar
 
Natural products as leads for new pharmaceuticals
Natural products as leads  for new pharmaceuticalsNatural products as leads  for new pharmaceuticals
Natural products as leads for new pharmaceuticals
Shikha Popali
 
Role of chirality in stereoselective and specific theraputic agent
Role of chirality in stereoselective and specific theraputic agentRole of chirality in stereoselective and specific theraputic agent
Role of chirality in stereoselective and specific theraputic agent
Karanvir Rajput
 
Biological Drug Targets.pptx
Biological Drug Targets.pptxBiological Drug Targets.pptx
Biological Drug Targets.pptx
VarshaJindaniya
 

What's hot (20)

Strategies for Heterocycle ring synthesis
Strategies for Heterocycle ring synthesis Strategies for Heterocycle ring synthesis
Strategies for Heterocycle ring synthesis
 
Traube purine synthesis
Traube purine synthesisTraube purine synthesis
Traube purine synthesis
 
Protecting groups
Protecting groupsProtecting groups
Protecting groups
 
Rational design of non- covalently and covalently binding.pptx
Rational design of non- covalently and covalently binding.pptxRational design of non- covalently and covalently binding.pptx
Rational design of non- covalently and covalently binding.pptx
 
Active constituent of drugs used in diabetic therapy
Active constituent of drugs used in diabetic therapyActive constituent of drugs used in diabetic therapy
Active constituent of drugs used in diabetic therapy
 
AMC PPT 4.pptx
AMC PPT 4.pptxAMC PPT 4.pptx
AMC PPT 4.pptx
 
Ullmann reaction
Ullmann reaction   Ullmann reaction
Ullmann reaction
 
01.Rational Design of Enzyme inhibition.pptx
01.Rational Design of Enzyme inhibition.pptx01.Rational Design of Enzyme inhibition.pptx
01.Rational Design of Enzyme inhibition.pptx
 
Wittig reagent
Wittig reagentWittig reagent
Wittig reagent
 
Chemistry of Prostaglandins, leukotrienes and thromboxanes(Advance medicinal ...
Chemistry of Prostaglandins, leukotrienes and thromboxanes(Advance medicinal ...Chemistry of Prostaglandins, leukotrienes and thromboxanes(Advance medicinal ...
Chemistry of Prostaglandins, leukotrienes and thromboxanes(Advance medicinal ...
 
Pinner pyrimidine synthesis
Pinner pyrimidine  synthesisPinner pyrimidine  synthesis
Pinner pyrimidine synthesis
 
Natural chemistry Structure elucidation of Emetine
Natural chemistry Structure elucidation of EmetineNatural chemistry Structure elucidation of Emetine
Natural chemistry Structure elucidation of Emetine
 
Protecting Groups in Organic Chemistry
Protecting Groups in Organic ChemistryProtecting Groups in Organic Chemistry
Protecting Groups in Organic Chemistry
 
01. Combating Drug Resistance.pptx
01. Combating Drug Resistance.pptx01. Combating Drug Resistance.pptx
01. Combating Drug Resistance.pptx
 
"Chemistry of Prostaglandins & Leukotrienes" , Tathagata Pradhan , Department...
"Chemistry of Prostaglandins & Leukotrienes" , Tathagata Pradhan , Department..."Chemistry of Prostaglandins & Leukotrienes" , Tathagata Pradhan , Department...
"Chemistry of Prostaglandins & Leukotrienes" , Tathagata Pradhan , Department...
 
TRAUBE PURINE SYNTHESIS.pptx
TRAUBE PURINE SYNTHESIS.pptxTRAUBE PURINE SYNTHESIS.pptx
TRAUBE PURINE SYNTHESIS.pptx
 
Chemistry of Natural Products, Morphine Alkaloids.pptx
Chemistry of Natural Products, Morphine Alkaloids.pptxChemistry of Natural Products, Morphine Alkaloids.pptx
Chemistry of Natural Products, Morphine Alkaloids.pptx
 
Natural products as leads for new pharmaceuticals
Natural products as leads  for new pharmaceuticalsNatural products as leads  for new pharmaceuticals
Natural products as leads for new pharmaceuticals
 
Role of chirality in stereoselective and specific theraputic agent
Role of chirality in stereoselective and specific theraputic agentRole of chirality in stereoselective and specific theraputic agent
Role of chirality in stereoselective and specific theraputic agent
 
Biological Drug Targets.pptx
Biological Drug Targets.pptxBiological Drug Targets.pptx
Biological Drug Targets.pptx
 

Similar to Cox inhibitor

Anti rheumatic drug ( NSAIDs and DMARDs )
Anti rheumatic drug ( NSAIDs and DMARDs )Anti rheumatic drug ( NSAIDs and DMARDs )
Anti rheumatic drug ( NSAIDs and DMARDs )
EL Sayed Sabry
 
Antipyretic-Analgesic-Nonsteroidal-Antiinflammatory-Drugs.03.Mar.2011.ppt
Antipyretic-Analgesic-Nonsteroidal-Antiinflammatory-Drugs.03.Mar.2011.pptAntipyretic-Analgesic-Nonsteroidal-Antiinflammatory-Drugs.03.Mar.2011.ppt
Antipyretic-Analgesic-Nonsteroidal-Antiinflammatory-Drugs.03.Mar.2011.ppt
IBNSINA National Medical College
 
Drug induced liver injury (DILI) and Hepatotoxicity
Drug induced liver injury (DILI) and HepatotoxicityDrug induced liver injury (DILI) and Hepatotoxicity
Drug induced liver injury (DILI) and Hepatotoxicity
Dr. Ankit Gaur
 
druginducedliverdisorder-190326032807.pdf
druginducedliverdisorder-190326032807.pdfdruginducedliverdisorder-190326032807.pdf
druginducedliverdisorder-190326032807.pdf
AshishSharma907946
 
Pain and inflammation treatment with NSID drugs
Pain and inflammation treatment with NSID drugs Pain and inflammation treatment with NSID drugs
Pain and inflammation treatment with NSID drugs
Akshay Kumar
 
Nsaids
NsaidsNsaids
Nsaids
raheel ahmad
 
NSAIDS.pptx
NSAIDS.pptxNSAIDS.pptx
NSAIDS.pptx
Najeeb Ur Rahman
 
Pharmacology review commonly used drugs
Pharmacology review commonly used drugsPharmacology review commonly used drugs
Pharmacology review commonly used drugs
stanbridge
 
Pharmacology review commonly used drugs
Pharmacology review commonly used drugsPharmacology review commonly used drugs
Pharmacology review commonly used drugs
stanbridge
 
Non steroidal anti inflammatory drugs
Non steroidal anti inflammatory drugsNon steroidal anti inflammatory drugs
Non steroidal anti inflammatory drugsNimra Iqbal
 
NSAIDs.pptx
NSAIDs.pptxNSAIDs.pptx
NSAIDs.pptx
FarazaJaved
 
NSAIDs.pptx
NSAIDs.pptxNSAIDs.pptx
NSAIDs.pptx
Dr. Sarita Sharma
 
Antipyretic, analgesic
Antipyretic,  analgesicAntipyretic,  analgesic
Antipyretic, analgesic
MrunalAkre
 
Analgesics.pptx
Analgesics.pptxAnalgesics.pptx
Analgesics.pptx
eyobkaseye
 
Analgesics
Analgesics Analgesics
Analgesics
Amira Badr
 
Non steroidal anti-inflammatory drugs.pptx
Non steroidal anti-inflammatory drugs.pptxNon steroidal anti-inflammatory drugs.pptx
Non steroidal anti-inflammatory drugs.pptx
ABIDOFFICIALCHANNEL
 
Role of drugs in orthodontics
Role of drugs in orthodonticsRole of drugs in orthodontics
Role of drugs in orthodontics
Indian dental academy
 
Non Steroidal Anti Inflammatory Drugs
Non Steroidal Anti Inflammatory DrugsNon Steroidal Anti Inflammatory Drugs
Non Steroidal Anti Inflammatory Drugs
Dr Rayan Malick
 

Similar to Cox inhibitor (20)

Anti rheumatic drug ( NSAIDs and DMARDs )
Anti rheumatic drug ( NSAIDs and DMARDs )Anti rheumatic drug ( NSAIDs and DMARDs )
Anti rheumatic drug ( NSAIDs and DMARDs )
 
Nsaial
NsaialNsaial
Nsaial
 
Antipyretic-Analgesic-Nonsteroidal-Antiinflammatory-Drugs.03.Mar.2011.ppt
Antipyretic-Analgesic-Nonsteroidal-Antiinflammatory-Drugs.03.Mar.2011.pptAntipyretic-Analgesic-Nonsteroidal-Antiinflammatory-Drugs.03.Mar.2011.ppt
Antipyretic-Analgesic-Nonsteroidal-Antiinflammatory-Drugs.03.Mar.2011.ppt
 
Drug induced liver injury (DILI) and Hepatotoxicity
Drug induced liver injury (DILI) and HepatotoxicityDrug induced liver injury (DILI) and Hepatotoxicity
Drug induced liver injury (DILI) and Hepatotoxicity
 
druginducedliverdisorder-190326032807.pdf
druginducedliverdisorder-190326032807.pdfdruginducedliverdisorder-190326032807.pdf
druginducedliverdisorder-190326032807.pdf
 
NSAIDS
NSAIDSNSAIDS
NSAIDS
 
Pain and inflammation treatment with NSID drugs
Pain and inflammation treatment with NSID drugs Pain and inflammation treatment with NSID drugs
Pain and inflammation treatment with NSID drugs
 
Nsaids
NsaidsNsaids
Nsaids
 
NSAIDS.pptx
NSAIDS.pptxNSAIDS.pptx
NSAIDS.pptx
 
Pharmacology review commonly used drugs
Pharmacology review commonly used drugsPharmacology review commonly used drugs
Pharmacology review commonly used drugs
 
Pharmacology review commonly used drugs
Pharmacology review commonly used drugsPharmacology review commonly used drugs
Pharmacology review commonly used drugs
 
Non steroidal anti inflammatory drugs
Non steroidal anti inflammatory drugsNon steroidal anti inflammatory drugs
Non steroidal anti inflammatory drugs
 
NSAIDs.pptx
NSAIDs.pptxNSAIDs.pptx
NSAIDs.pptx
 
NSAIDs.pptx
NSAIDs.pptxNSAIDs.pptx
NSAIDs.pptx
 
Antipyretic, analgesic
Antipyretic,  analgesicAntipyretic,  analgesic
Antipyretic, analgesic
 
Analgesics.pptx
Analgesics.pptxAnalgesics.pptx
Analgesics.pptx
 
Analgesics
Analgesics Analgesics
Analgesics
 
Non steroidal anti-inflammatory drugs.pptx
Non steroidal anti-inflammatory drugs.pptxNon steroidal anti-inflammatory drugs.pptx
Non steroidal anti-inflammatory drugs.pptx
 
Role of drugs in orthodontics
Role of drugs in orthodonticsRole of drugs in orthodontics
Role of drugs in orthodontics
 
Non Steroidal Anti Inflammatory Drugs
Non Steroidal Anti Inflammatory DrugsNon Steroidal Anti Inflammatory Drugs
Non Steroidal Anti Inflammatory Drugs
 

More from shinganaarti

Acid and base buffer
Acid and base   bufferAcid and base   buffer
Acid and base buffer
shinganaarti
 
Pharmacopoeia
PharmacopoeiaPharmacopoeia
Pharmacopoeia
shinganaarti
 
Nomenclature
NomenclatureNomenclature
Nomenclature
shinganaarti
 
Limit test
Limit test Limit test
Limit test
shinganaarti
 
Impurites
Impurites Impurites
Impurites
shinganaarti
 
Recrysatlization
RecrysatlizationRecrysatlization
Recrysatlization
shinganaarti
 
Introduction to pharmacology
Introduction to pharmacologyIntroduction to pharmacology
Introduction to pharmacology
shinganaarti
 
Protecting group
Protecting groupProtecting group
Protecting group
shinganaarti
 

More from shinganaarti (8)

Acid and base buffer
Acid and base   bufferAcid and base   buffer
Acid and base buffer
 
Pharmacopoeia
PharmacopoeiaPharmacopoeia
Pharmacopoeia
 
Nomenclature
NomenclatureNomenclature
Nomenclature
 
Limit test
Limit test Limit test
Limit test
 
Impurites
Impurites Impurites
Impurites
 
Recrysatlization
RecrysatlizationRecrysatlization
Recrysatlization
 
Introduction to pharmacology
Introduction to pharmacologyIntroduction to pharmacology
Introduction to pharmacology
 
Protecting group
Protecting groupProtecting group
Protecting group
 

Recently uploaded

Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Po-Chuan Chen
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
CarlosHernanMontoyab2
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 

Recently uploaded (20)

Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 

Cox inhibitor

  • 1. Miss. Aarti V. Shingan M. Pharm in pharmaceutical Chemistry
  • 2.  Known as :prostaglandin-endoperoxide synthase(PTGS)  Responsible for formation of prostanoides 1.prostaglandin,  2.thamboxen,  3.prostacylin.  Involved in the inflammtory Responce.
  • 3.  Contains two separate active sites for prostaglandin synthase  One side contains the cyclooxygenase active  The Opposite active side active side contains peroxidase active site which is Involved in activating the heme group neccesory for cyclooxygenase reaction  It has two forms COX-1 and COX-2.
  • 4.  Continiously stimulate by the body  Constitutive (its concentration in the body remain stable)  creates prostaglandin uses for basic house keeping throughout the body  Prostaglandin stimulate normal body function such as stomach mucous production, regulation of gastric acid and kidney water
  • 5.  Induced ( normally not in present in cells)  Built only in special cells (Ex: lung cells)  Used for singnaling pain and inflamation  Produces prostaglandins for inflammtory responce  Stimulated only as part of immune responce  Production is stimulated by inflammtory cytokines and growth factors
  • 6.
  • 7.
  • 10. IUPAC Name : 1-(p-Chloro benzoyl) 5- methoxy indole-3-acitic acid
  • 11. Properties : Colour: pale yellow appearance: crystalline powder solubility: soluble in water sparingly soluble in alcohol M.P : 155-162 0C chemical formula: C19H21ClNNaO7 Assay: the sample in acetone and pass nitrogen for 15 min and titrate with 0.1M NAOH using phenolphthalein as indicator.
  • 12. 1. The centre of acidity is usually located one carbon atom adjecent to a flat surface represented by an aromatic or hetero aromatic ring . 2. The distance between these centre is critical because increasing this distance to two or three carbon generally decreasing activity. 3. Increasing acidity of of COOH group Increasing activity. 4. Substitution of methyl group on the carbon atom separating the aromatic ring leads to the enhancement of anti- inflammatory activity.
  • 13. P –methoxy phenyl hydrazine hydrazone indomethacin
  • 14. Mechanism of action : indomethacin ,a non –steroidal anti-inflmmatory drug (NSAIDs) ,it is a selective COX-1 inhibitor the enzyme that participate in prostaglandin synthesis from archidonic acid Prostaglandin are hormone like molecule normally found in the body , where they have a wide variety of effects, some of which leads to pain ,fever, and inflammation. By inhibiting the synthesis of prostaglandins , indomethacin can reduce pain, fever, and inflammation.
  • 15. Medical uses:  indomethacin is an analgesic,antipyretic and anti- inflammatory . Clinical indication for indomethacin include :  Joint diseases : rheumatoid arthritis ,oateoarthritis ,gouty arthritis ;Headaches etc Adverse effect: peptic ulcer ,dypepsia,heartburn,mild dirrhea ,edema9swelling due to fluid retention ) , hyperkalemia(highpotassiumlevel), hypernatremia(high sodium level ) .
  • 16.  IUPAC Name : 2-(4-isobutyl phenyl) propionic acid
  • 17. Properties : Colour: colourless , appearance: crystalline powder solubility: insoluble in water, soluble in most organic solvents like alcohols, acetone,and dichloromethane. M.P : 75-780C chemical formula: C13H18O2 Assay: Dissolve the sample in methanol and titrate against 0.1M NaOH USING Phenolphthalin indicator as indicator ,until colour is obtained .
  • 18.
  • 19. Mechanism of action: it is a non –steroidal anti-inflmmatory drug (NSAIDs) ,it is a selective COX-1 inhibitor the enzyme that participate in prostaglandin synthesis from archidonic acid Prostaglandin are hormone like molecule normally found in the body , where they have a wide variety of effects, some of which leads to pain ,fever, and inflammation. By inhibiting the synthesis of prostaglandins , ibuprofen can reduce pain, fever, and inflammation
  • 20. Medical uses:  Ibuprofen is used primarily to treat fever (including post- vaccination fever),  mild to moderate pain (including pain relief after surgery), painful menstruation, osteoarthritis, dental pain, headaches, and pain from kidney stones.  About 60% of people respond to any NSAID; those who do not respond well to a particular one may respond to another.  It is used for inflammatory diseases such as juvenile idiopathic arthritis and rheumatoid arthritis.  It is also used for pericarditis and patent ductus arteriosus.
  • 21. Adverse effects :  include nausea, dyspepsia, diarrhea, constipation, gastrointestinal ulceration/bleeding, headache, dizziness, rash, salt and fluid retention, and high blood pressure.  Infrequent adverse effects include esophageal ulceration, heart failure, high blood levels of potassium, kidney impairment, confusion, and bronchospasm.Ibuprofen can exacerbate asthma
  • 22.  IUPAC name : 2-(6-methoxy 2-naphthyl) propionic acid
  • 23. Properties : Colour: white appearance: crystalline powder solubility insoluble in water, soluble in most organic solvents like methanol,ethanol. M.P : 155-162 0C chemical formula: C19H21ClNNaO7 Assay: dissolve the sample in a mixture of water and methanol(1:3)and titrate with 0.1M NAOH using phenolphthalein as indicator.
  • 24.
  • 25. Mechanism of action: it is a non –steroidal anti- inflmmatory drug (NSAIDs) ,it is a selective COX-1 inhibitor the enzyme that participate in prostaglandin synthesis from archidonic acid Prostaglandin are hormone like molecule normally found in the body , where they have a wide variety of effects, some of which leads to pain ,fever, and inflammation. By inhibiting the synthesis of prostaglandins , naproxen can reduce pain, fever, and inflammation.
  • 26. Medical uses : Inflammatory sources of pain that may respond to naproxen's anti-inflammatory activity are conditions  such as migraine,  osteoarthritis,  kidney stones,  rheumatoid arthritis,  psoriatic arthritis,  gout,  ankylosing spondylitis,  menstrual cramps, tendinitis, and bursitis.
  • 27. adverse effects: include  dizziness, drowsiness,  headache,  rash,  bruising,  gastrointestinal upset.  Heavy use is associated with increased risk of end- stage renal disease and kidney failure.
  • 29. Properties : Colour: light yellow, appearance: crystalline powder solubility soluble in water, slightly soluble solvents like methanol,ethanol. M.P : 155-157 0C chemical formula: C15H15NO3
  • 30.
  • 31. Mechanism of action:  Although the mechanism of action of tolmetin is unknown, research involving humans and animals has shown that tolmetin does not achieve anti-inflammatory response by stimulation of the adrenal or pituitary gland,  but it has shown tolmetin restrains prostaglandin synthetase in vitro and reduces plasma levels of prostaglandin E, possibly causing the anti-inflammatory response.
  • 32. Medical uses: Is used alone or with other treatment to reduce pain , swelling, and joint stiffness from rheumatoid arthritis and osteoarthritis . It is used for juvenile rheumatoid arthrites Adverse effect:  Tolmetin can increase the risk of heart or circulatory conditions such as heart attacks and strokes. It should not be taken shortly before or after coronary artery bypass surgery.  Tolmetin can also increase the risk of gastrointestinal conditions such as perforation or bleeding, which is fatal. Antacids can be taken with tolmetin to relieve stomachaches that often occur.  Overdose can result in drowsiness, nausea, epigastric pain, and vomiting
  • 33. Adverse effect:  Tolmetin can increase the risk of heart or circulatory conditions such as heart attacks and strokes.  It should not be taken shortly before or after coronary artery bypass surgery.  Tolmetin can also increase the risk of gastrointestinal conditions such as perforation or bleeding, which is fatal. Antacids can be taken with tolmetin to relieve stomachaches that often occur.  Overdose can result in drowsiness, nausea, epigastric pain, and vomiting.
  • 34.
  • 36. Properties : Colour: pale yellow appearance: crystalline powder solubility: soluble in water sparingly soluble in alcohol M.P : 157-159 0C chemical formula: C17H14FNO2S
  • 37.  A para-sulfamoylphenyl at position 1 of the pyrazole was found to have a higher potency for COX-2 selective inhibition.  At the 3-position of the pyrazole, a trifluoromethyl or difluoromethyl provides superior selectivity and potencyCelecoxib is compound 22;  the 4-sulfamoylphenyl on the 1-pyrazol substituent is required for COX-2 inhibition and the 4-methyl on the 5- pyrazol system has low steric hindrance to maximize potency,  while the 3-trifluoromethyl group provides superior selectivity and potency.  To explain the selectivity of celecoxib, it is necessary to analyze the free energy of binding difference between the drug molecule and COX-1 compared to COX-2 enzymes
  • 38.
  • 39.  Celecoxib is used for osteoarthritis, rheumatoid arthritis, acute pain, musculoskeletal pain, painful menstruation, ankylosing spondylitis, and to reduce the number of colon and rectal polyps in people with familial adenomatous polyposis.  It may also be used in children with juvenile rheumatoid arthritis who are older than two years of age and weigh more than 10 kg (22 lb). Mental illness  Tentative evidence supports its use in treating a number of psychiatric disonrders, including major depression, bipolar disorder, and schizophrenia.  Familial adenomatous polyposis
  • 40. Adverce effect:  Cardiovascular events: NSAIDs are associated with an increased risk of serious (and potentially fatal) adverse cardiovascular thrombotic events, including myocardial infarction and stroke  Gastrointestinal events: NSAIDs may increase risk of serious gastrointestinal (GI) ulceration, bleeding, and perforation (may be fatal). These events may occur at any time during therapy and without warning.  Use cautionHematologic effects: Anemia may occur; monitor hemoglobin or hematocrit in people on long- term treatment. Celecoxib does not usually affect prothrombin time, partial thromboplastin time or platelet counts; it does not inhibit platelet aggregation at approved doses.  with a history of GI disease (bleeding or ulcers).
  • 42. Properties : Colour: light yellow appearance: crystalline powder solubility: . Soluble in 1- octanol ,soluble in water sparingly soluble in alcohol , acetone M.P : 155-162 0C chemical formula: C17H14O4S
  • 43.
  • 44. ROFICOXIB Mechanism of action Cyclooxygenase (COX) has two well-studied isoforms, called COX-1 and COX-2. COX-1 mediates the synthesis of prostaglandins responsible for protection of the stomach lining, while COX-2 mediates the synthesis of prostaglandins responsible for pain and inflammation. By creating "selective" NSAIDs that inhibit COX-2, but not COX-1, the same pain relief as traditional NSAIDs is offered, but with greatly reduced risk of fatal or debilitating peptic ulcers. Rofecoxib is a selective COX-2 inhibitor, or "coxib"
  • 45.  Medical uses :Rofecoxib is a nonsteroidal anti-inflammatory drug that was used in the treatment of osteoarthritis, acute pain conditions, and dysmenorrhoea.  Adverce effect:Aside from the reduced incidence of gastric ulceration, rofecoxib exhibits a similar adverse effect profile to other NSAIDs.